Subject: New Client Allezoe Medical Holdings (ALZM) Announces Acquisition Agreement

SCV Client Spotlight ALZM Logo
New acquistion already featured on The Doctor's Show, Fox and Friends television, The Tyra Banks Show and other television and radio shows

Allezoe Medical Holdings Inc.
1800 NW Corporate Boulevard Suite 201
Boca Raton, FL 33431
Phone: 321-452-9091


Allezoe Medical Holdings, Inc. (ALZM) is a holding company focused on acquiring the most high-quality and in demand medical products, solutions and services.

We believe it is possible to create value for shareholders as well as recipients of healthcare services at the same time, and we do so through acquisition and support of technologies that improve healthcare delivery and address the most urgent health issues facing the world today. Whether through diagnosis, treatment, or medical research itself, Allezoe is interested in companies that are making a striking difference in the healthcare system through technology and treatments for health issues that affect large populations.

Allezoe Medical Holdings' subsidiary, SureScreen Medical, Inc., has signed an exclusive license to develop and market a breakthrough medical technology that will, potentially, revolutionize the diagnosis and treatment of Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer. HPV is the most common sexually transmitted infection -- there are more than 40 types -- and most people who become infected do not know they have it, leading to further spread. Approximately 20 million Americans are infected with HPV and it is estimated that 5.5 million people will contract it each year.

The potential impact of the SureScreen© technology is particularly important with regard to cervical cancer, the second most common cancer in women. Cervical cancer can be prevented with the right technologies and treatments. SureScreen's© See-&-Treat© technology aims to replace the existing practice of testing a patient for HPV and requiring her to return to a healthcare provider for the results and, if necessary, treatment with a single-visit solution. Especially in third-world regions, diagnosing and treating HPV in women in a single visit can significantly raise the level of treatment and, potentially, severely reduce cervical cancer rates.



The recent acquisition of the OV-Watch technology will add another cutting-edge medical device technology to the growing line up of Allezoe Medical subsidiaries. OVWatch ( is a privately held medical device company focused on solutions for infertility problems in couples seeking to have children.

  • OV-Watch® is a non-invasive, wrist watch-like medical device that provides four days advance notice of ovulation to maximize conception opportunities. The product is FDA cleared (510k) is currently being marketed in the US and is also approved in Canada and Europe.
  • The OV-Watch has been featured on The Doctor's Show, Fox and Friends television, The Tyra Banks Show and other television and radio shows and is available on-line.

Allezoe Medical Holdings is in the final stages of discussions to acquire a number of organizations including companies that:

  • Diagnosis and treatment of Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer. Human Papillomavirus (HPV) is the most common sexually transmitted infection. Approximately 20 million Americans are infected with HPV and it is expected that 5.5 million will contract the HPV through sexual contact each year.
  • State-of-the-art implant technologies for spinal surgery
  • Do clinical trial research
ALZM Chart


Market Value:
2,580,144M as of Jul 12, 2012

Shares Outstanding:
373,933,918 as of Apr 23, 2012

Authorized Shares:
500,000,000 as of Dec 01, 2010

Shareholders of Record:
71 as of Jul 11, 2012

Transfer Agent:
Holladay Stock Transfer


Allezoe Medical Holdings (ALZM) Announces Acquisition Agreement

Allezoe (ALZM) Announces New Management for SureScreen Medical


Caroline Pinell

Chief Operating Officer

Michael Gelmon, LL.B

Hyman White

Michael Choo

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks